Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis.
Mumbai: Piramal Enterprises said on Wednesday that it will raise up to Rs 2,750 crore by issuing bonds on private placement basis.
"A meeting of the administrative committee of the board of directors will be held on December 28 to consider and approve the issue of secured non-convertible debentures on private placement basis amounting up to Rs 2,750 crore," it said in regulatory filings at stock exchanges.
Piramal Enterprises said the money can be raised in one or more tranches from time to time.
Read Also: Subscription of Piramal debentures by Canadian investor approved by CCI
In October, the board of Piramal Enterprises had approved fresh capital raising of Rs 5,400 crore through a rights issue and preferential allotment of compulsory convertible debentures.
The funds are expected to strengthen the company's balance sheet and aid it in consolidation across financial services, pharmaceuticals and information management businesses.
Read Also: Piramal Pharma, BerGenBio enter partnership for developing leukemia drug Bemcentinib
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd